Status:
RECRUITING
A Cohort of Patients Undergoing Percutaneous Coronary Intervention
Lead Sponsor:
Su Guohai
Collaborating Sponsors:
Shandong First Medical University
Conditions:
Acute Coronary Syndrome
Percutaneous Coronary Intervention
Eligibility:
All Genders
18-85 years
Brief Summary
To investigate the risk factors involved in the occurrence and prognosis of the patients with acute coronary syndrome, patients undergoing percutaneous coronary intervention will be recruited and foll...
Detailed Description
Patients with acute coronary syndrome undergoing percutaneous coronary intervention will be recruited and prospectively followed up for the incidence of major adverse cardiovascular events (MACE event...
Eligibility Criteria
Inclusion Criteria:
- Diagnosed as acute coronary syndrome and needed to undergo percutaneous coronary intervention.
- >18 years old.
Exclusion Criteria:
- With malignant tumors, acute infectious diseases and advanced liver diseases.
- Won't sign an inform consent.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT05719545
Start Date
December 1 2021
End Date
December 30 2026
Last Update
February 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinan Central Hospital
Jinan, Shandong, China